Vergelijking

Pramlintid vs. Semaglutid

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Metabool

CAS-nr.

151126-32-8

910463-68-2

Molecuulmassa

3949.4 g/mol

4113.6 g/mol

Halfwaardetijd

geen gegevens

165 h

Sequentie

geen gegevens

modifiziertes GLP-1-Analogon (31 AS) mit C18-Fettsäure-Linker

Werkingsmechanisme

Pramlintid

Pramlintide mimics the beta-cell hormone amylin, which is co-secreted with insulin. It slows gastric emptying, suppresses postprandial glucagon release and promotes satiety — thereby blunting post-meal blood-glucose spikes.

Semaglutid

Long-acting agonist at the GLP-1 receptor. Structurally a modified glucagon-like peptide 1 whose long half-life is achieved via a fatty-acid side chain and reversible albumin binding. Acts centrally on satiety and peripherally on glucose-dependent insulin secretion and delayed gastric emptying.

Bewijsbasis

Hoogste bewijs

Humane RCT

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Pramlintid	Semaglutid
Zwitserland	—	Op recept
Duitsland	Niet goedgekeurd	Op recept
Verenigde Staten	Op recept	Op recept

Volledige vermeldingen

Pramlintid

Volledige vermelding →

Semaglutid

Volledige vermelding →

Frequently asked questions

What is the difference between Pramlintid and Semaglutid?: Pramlintid is classified as "Metabool", while Semaglutid is classified as "Metabool". Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. Semaglutid: Long-acting GLP-1 receptor agonist. Approved as a medicinal product for type-2 diabetes (Ozempic, Rybelsus), chronic weight management (Wegovy) and cardiovascular risk in obesity. One of the best-studied substances on this platform — many large human RCTs. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Pramlintid or Semaglutid?: The highest available evidence level is "Humane RCT" for Pramlintid and "Humane RCT" for Semaglutid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Pramlintid and Semaglutid in Germany and the United States?: Duitsland: Pramlintid — Niet goedgekeurd, Semaglutid — Op recept. Verenigde Staten: Pramlintid — Op recept, Semaglutid — Op recept. These are factual summaries with source and review date on the individual pages.

Country

Pramlintid

Semaglutid

Zwitserland

—

Op recept

Duitsland

Niet goedgekeurd

Op recept

Verenigde Staten

Op recept

Frequently asked questions

What is the difference between Pramlintid and Semaglutid?

Pramlintid is classified as "Metabool", while Semaglutid is classified as "Metabool". Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. Semaglutid: Long-acting GLP-1 receptor agonist. Approved as a medicinal product for type-2 diabetes (Ozempic, Rybelsus), chronic weight management (Wegovy) and cardiovascular risk in obesity. One of the best-studied substances on this platform — many large human RCTs. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Pramlintid or Semaglutid?

The highest available evidence level is "Humane RCT" for Pramlintid and "Humane RCT" for Semaglutid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Pramlintid and Semaglutid in Germany and the United States?

Duitsland: Pramlintid — Niet goedgekeurd, Semaglutid — Op recept. Verenigde Staten: Pramlintid — Op recept, Semaglutid — Op recept. These are factual summaries with source and review date on the individual pages.